Interleukin-1-receptor-antagonist inhibits migratory and invasive capacity of bladder cancer cells in vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2022
- Schlagwort
-
Blasenkrebs
Interleukin 1
- DOI
-
10.18725/OPARU-47757
- URN
-
urn:nbn:de:bsz:289-oparu-47833-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schneider, Lisa Sophie
- Universität Ulm
Entstanden
- 2023
Ähnliche Objekte (12)
Protein interactome of muscle invasive bladder cancer
Loss of FAT4 induces aneuploidy in urothelial cells and promotes the invasive and migratory capacities of bladder cancer cell lines
GJB3 controls ploidy of urothelial cells and the invasive and migratory capacities of bladder cancer cells through interactions with α-Tubulin and F-Actin
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
Chronic sulforaphane administration inhibits resistance to the mTOR-inhibitor everolimus in bladder cancer cells
Antagonist
Migratory birds
The role of CCN3 (NOV) on migratory and invasive properties of trophoblast cells
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
Lysine methyltransferase 9 (KMT9) is an actionable target in muscle-invasive bladder cancer
Protein interactome of muscle invasive bladder cancer
Loss of FAT4 induces aneuploidy in urothelial cells and promotes the invasive and migratory capacities of bladder cancer cell lines
GJB3 controls ploidy of urothelial cells and the invasive and migratory capacities of bladder cancer cells through interactions with α-Tubulin and F-Actin
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
Chronic sulforaphane administration inhibits resistance to the mTOR-inhibitor everolimus in bladder cancer cells
Antagonist
Migratory birds
The role of CCN3 (NOV) on migratory and invasive properties of trophoblast cells
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
Lysine methyltransferase 9 (KMT9) is an actionable target in muscle-invasive bladder cancer
Protein interactome of muscle invasive bladder cancer
Loss of FAT4 induces aneuploidy in urothelial cells and promotes the invasive and migratory capacities of bladder cancer cell lines
GJB3 controls ploidy of urothelial cells and the invasive and migratory capacities of bladder cancer cells through interactions with α-Tubulin and F-Actin
Bioinformatics modeling of proteomics changes in muscle invasive bladder cancer
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
Chronic sulforaphane administration inhibits resistance to the mTOR-inhibitor everolimus in bladder cancer cells
Antagonist
Migratory birds
The role of CCN3 (NOV) on migratory and invasive properties of trophoblast cells
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer